{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:03:34Z","timestamp":1768406614312,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04537-x","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:44:00Z","timestamp":1761655440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inappropriate GFR equations misrepresent CKD epidemiology and risk interpretation in scientific reports"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-0924","authenticated-orcid":false,"given":"Sina","family":"Bazmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrollah","family":"Ghahramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Farjam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"19","key":"4537_CR1","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"4","key":"4537_CR2","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"key":"4537_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2369-11-8","volume":"11","author":"P Delanaye","year":"2010","unstructured":"Delanaye P, Cavalier E, Mariat C, Maillard N, Krzesinski JM. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol. 2010;11:8.","journal-title":"BMC Nephrol"},{"issue":"4","key":"4537_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.ajkd.2009.12.016","volume":"55","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD epidemiology collaboration (CKD-EPI) equation compared with the MDRD study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2010;55(4):648\u201359.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4537_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrneph.2013.143","volume":"9","author":"P Delanaye","year":"2013","unstructured":"Delanaye P, Mariat C. The applicability of eGFR equations to different populations. Nat Rev Nephrol. 2013;9(9):513\u201322.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4537_CR6","first-page":"76","volume":"14","author":"S Abbasi","year":"2023","unstructured":"Abbasi S, Bigharaz E, Farsaei S, Mansourian M. Could melatonin prevent Vancomycin-induced nephrotoxicity in critically ill patients? A randomized, double-blinded controlled trial. Casp J Intern Med. 2023;14(1):76\u201382.","journal-title":"Casp J Intern Med"},{"key":"4537_CR7","doi-asserted-by":"publisher","first-page":"1496505","DOI":"10.3389\/fmed.2024.1496505","volume":"11","author":"VG Chegini","year":"2024","unstructured":"Chegini VG, Kazemifar AM, Tavakolian AE, Karimi AG, Sofi AJP, Ipchian D, et al. Evaluating the effect of chronic and continuous use of methadone on the glomerular filtration rate of patients receiving oral methadone (syrup). Front Med (Lausanne). 2024;11:1496505.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"4537_CR8","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.4103\/jfmpc.jfmpc_1344_21","volume":"11","author":"S Golshani","year":"2022","unstructured":"Golshani S, Tavasoli P, Farsavian AA, Farsavian H, Charati JY. Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin. J Family Med Prim Care. 2022;11(5):1957\u201362.","journal-title":"J Family Med Prim Care"},{"issue":"3","key":"4537_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/aca.aca_84_22","volume":"26","author":"S Khademi","year":"2023","unstructured":"Khademi S, Heirany F, Jouybar R, Dehghanpisheh L, Ghazinoor M, Mehr LS. Effect of albumin usage during cardiopulmonary bypass on postoperative acute kidney injury in cardiac surgery patients: A historical cohort study. Ann Card Anaesth. 2023;26(3):288\u201394.","journal-title":"Ann Card Anaesth"},{"issue":"4","key":"4537_CR10","first-page":"205","volume":"17","author":"S Mohammadi Kebar","year":"2023","unstructured":"Mohammadi Kebar S, Atighi E, Hosseninia S, Babapour B. Preventive effects of Nicorandil and Atorvastatin in contrastinduced nephropathy in patients with renal dysfunction undergoing coronary artery angiography: A double Blind, Randomized, controlled clinical trial. Iran J Kidney Dis. 2023;17(4):205\u201314.","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"4537_CR11","first-page":"31","volume":"10","author":"M Mohammadi-Sichani","year":"2022","unstructured":"Mohammadi-Sichani M, Radmanesh F, Taheri S, Ghadimi K, Khodadadi S, Salehi H, et al. Evaluation of glomerular filtration rate decline in patients with renal colic. Am J Clin Exp Urol. 2022;10(1):31\u20136.","journal-title":"Am J Clin Exp Urol"},{"issue":"128","key":"4537_CR12","first-page":"141","volume":"35","author":"M Motiee Langaroudi","year":"2023","unstructured":"Motiee Langaroudi M, Jafari M, Safari R, Sadeghi Ivraghi M, Mazarei A. Evaluation of the incidence of pharyngocutaneous fistula after total laryngectomy. Iran J Otorhinolaryngol. 2023;35(128):141\u20136.","journal-title":"Iran J Otorhinolaryngol"},{"key":"4537_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/abr.abr_292_21","volume":"12","author":"M Alizadeh Hadadhania","year":"2023","unstructured":"Alizadeh Hadadhania M, Ghaffari K, Absalan A, Eghbali A, Rahimi Afzal R, Ghasemi A, Eghbali A. Magnesium supplementation May not be protective against Carboplatin-Induced nephrotoxicity but May be beneficial for children suffering malignancies: A randomized clinical trial. Adv Biomed Res. 2023;12:11.","journal-title":"Adv Biomed Res"},{"issue":"12","key":"4537_CR14","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.4103\/jfmpc.jfmpc_627_22","volume":"11","author":"A Aref","year":"2022","unstructured":"Aref A, Khodhal M, Rashidi H, Farhangiyan Z, Bitaraf S. Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy. J Family Med Prim Care. 2022;11(12):7735\u201342.","journal-title":"J Family Med Prim Care"},{"issue":"9","key":"4537_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.34172\/aim.31194","volume":"27","author":"M Kheirandish","year":"2024","unstructured":"Kheirandish M, Eftekhar E, Azarbad A, Salarpour E, Shahmoradi M, Ghazizadeh S, et al. Prevalence of chronic kidney disease and associated factors among the diabetic and prediabetic population in the Bandare-Kong cohort study; A population-Based study. Arch Iran Med. 2024;27(9):470\u20138.","journal-title":"Arch Iran Med"},{"issue":"5","key":"4537_CR16","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/fsn3.2753","volume":"10","author":"J Moludi","year":"2022","unstructured":"Moludi J, Tandorost A, Kamari N, Abdollahzad H, Pakzad R, Najafi F, Pasdar Y. Dietary total antioxidant capacity and its association with renal function and kidney stones: results of a RaNCD cohort study. Food Sci Nutr. 2022;10(5):1442\u201350.","journal-title":"Food Sci Nutr"},{"key":"4537_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/ijpvm.ijpvm_9_22","volume":"14","author":"M Moosazadeh","year":"2023","unstructured":"Moosazadeh M, Espahbodi F, Afshari M, Eslami A. Can CBC profile and liver function test predict chronic kidney disease among a normal population? Int J Prev Med. 2023;14:2.","journal-title":"Int J Prev Med"},{"issue":"1","key":"4537_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12882-025-04018-1","volume":"26","author":"A Nazari","year":"2025","unstructured":"Nazari A, Jamali Z, Soltani N, Khalili P, Esmaeili-Nadimi A, Kahnoji M, et al. Kidney stone and risk of cardiovascular diseases: a cross-sectional study in the Southeast of Iran. BMC Nephrol. 2025;26(1):101.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4537_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12882-024-03566-2","volume":"25","author":"F Zarshenas","year":"2024","unstructured":"Zarshenas F, Dehghan A, Mirzaei M. Association between chronic kidney disease and cardiovascular disease risk factors in elderly: results from the first phase of Fasa and Shahedieh cohort studies. BMC Nephrol. 2024;25(1):413.","journal-title":"BMC Nephrol"},{"key":"4537_CR20","doi-asserted-by":"crossref","unstructured":"Gholipour S, Mohammadi Z, Bazmi S, Farahvashi P, Tabrizi R. Association of sleep parameters with kidney function: analysis of baseline data from 9216 adults in the Fasa adult cohort study (FACS). Clin Exp Nephrol. 2025.","DOI":"10.1007\/s10157-025-02720-w"},{"issue":"1","key":"4537_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12889-023-15463-8","volume":"23","author":"N Deravi","year":"2023","unstructured":"Deravi N, Sharifi Y, Koohi F, Zadeh SST, Masrouri S, Azizi F, Hadaegh F. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies. BMC Public Health. 2023;23(1):565.","journal-title":"BMC Public Health"},{"issue":"1","key":"4537_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12882-021-02655-w","volume":"23","author":"M Ghelichi-Ghojogh","year":"2022","unstructured":"Ghelichi-Ghojogh M, Fararouei M, Seif M, Pakfetrat M. Chronic kidney disease and its health-related factors: a case-control study. BMC Nephrol. 2022;23(1):24.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4537_CR23","doi-asserted-by":"publisher","first-page":"26511","DOI":"10.1038\/s41598-024-72685-5","volume":"14","author":"M Ghelichi-Ghojogh","year":"2024","unstructured":"Ghelichi-Ghojogh M, Fararouei M, Seif M, Pakfetrat M. Environmental factors and chronic kidney disease: a case-control study. Sci Rep. 2024;14(1):26511.","journal-title":"Sci Rep"},{"issue":"3","key":"4537_CR24","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1002\/edm2.413","volume":"6","author":"R Irilouzadian","year":"2023","unstructured":"Irilouzadian R, Afaghi S, Esmaeili Tarki F, Rahimi F, Malekpour Alamadari N. Urinary c-peptide creatinine ratio (UCPCR) as a predictor of coronary artery disease in type 1 diabetes mellitus. Endocrinol Diabetes Metab. 2023;6(3):e413.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"3","key":"4537_CR25","first-page":"141","volume":"17","author":"T Malakoutian","year":"2023","unstructured":"Malakoutian T, Izadi S, Honarpisheh P, Bagheri SM, Saffarzadeh N, Akbari H. Estimating patient survival and risk of End-Stage kidney disease in patients with autosomal dominant polycystic kidney disease in Iran. Iran J Kidney Dis. 2023;17(3):141\u20139.","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"4537_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40620-023-01756-z","volume":"37","author":"S Masrouri","year":"2024","unstructured":"Masrouri S, Tamehri Zadeh SS, Pishgahi M, Azizi F, Shapiro MD, Hadaegh F. Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran lipid and glucose study. J Nephrol. 2024;37(1):107\u201318.","journal-title":"J Nephrol"},{"issue":"13\u201314","key":"4537_CR27","doi-asserted-by":"publisher","first-page":"e24954","DOI":"10.1002\/jcla.24954","volume":"37","author":"A Yadegar","year":"2023","unstructured":"Yadegar A, Mohammadi F, Rabizadeh S, Ayati A, Seyedi SA, Nabipoorashrafi SA, et al. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross-sectional survey of a regional cohort. J Clin Lab Anal. 2023;37(13\u201314):e24954.","journal-title":"J Clin Lab Anal"},{"key":"4537_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"4537_CR29","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.dsx.2023.102780","volume":"17","author":"N Agustanti","year":"2023","unstructured":"Agustanti N, Soetedjo NNM, Damara FA, Iryaningrum MR, Permana H, Bestari MB, Supriyadi R. The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023;17(5):102780.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"4537_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"TY Wang","year":"2022","unstructured":"Wang TY, Wang RF, Bu ZY, Targher G, Byrne CD, Sun DQ, Zheng MH. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4537_CR31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa cohort study. BMC Public Health. 2016;16(1):1090.","journal-title":"BMC Public Health"},{"issue":"3","key":"4537_CR32","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/ije\/dyac241","volume":"52","author":"R Homayounfar","year":"2023","unstructured":"Homayounfar R, Farjam M, Bahramali E, Sharafi M, Poustchi H, Malekzadeh R, et al. Cohort profile: the Fasa adults cohort study (FACS): a prospective study of non-communicable diseases risks. Int J Epidemiol. 2023;52(3):e172\u20138.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"4537_CR33","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023\u201330.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4537_CR34","doi-asserted-by":"publisher","first-page":"101281","DOI":"10.1016\/j.aohep.2023.101281","volume":"29","author":"S Hong","year":"2024","unstructured":"Hong S, Sun L, Hao Y, Li P, Zhou Y, Liang X, et al. From NAFLD to MASLD: when metabolic comorbidity matters. Ann Hepatol. 2024;29(2):101281.","journal-title":"Ann Hepatol"},{"key":"4537_CR35","doi-asserted-by":"crossref","unstructured":"KDIGO. 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4s):S117-s314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"1","key":"4537_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341.","journal-title":"Nephron"},{"key":"4537_CR37","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"7","key":"4537_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"4537_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1681\/ASN.2010121321","volume":"22","author":"BO Eriksen","year":"2011","unstructured":"Eriksen BO, Melsom T, Mathisen UD, Jenssen TG, Solbu MD, Toft I. GFR normalized to total body water allows comparisons across genders and body sizes. J Am Soc Nephrol. 2011;22(8):1517\u201325.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4537_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"2","key":"4537_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1681\/ASN.2004060447","volume":"16","author":"ED Poggio","year":"2005","unstructured":"Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the Estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16(2):459\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4537_CR42","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/ndt\/gft006","volume":"28","author":"P Delanaye","year":"2013","unstructured":"Delanaye P, Pottel H, Botev R, Inker LA, Levey AS, Con. Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation? Nephrol Dial Transpl. 2013;28(6):1396\u2013403. discussion 403.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4537_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and Cystatin C. N Engl J Med. 2012;367(1):20\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"4537_CR44","doi-asserted-by":"publisher","first-page":"17664","DOI":"10.1038\/s41598-025-01531-z","volume":"15","author":"MS Shiri","year":"2025","unstructured":"Shiri MS, Karami H, Ghanbarnezhad A, Bordbar N, Mouseli A, Emamgholipour S. National and subnational trends in obesity prevalence in iran: a Spatiotemporal study with future predictions. Sci Rep. 2025;15(1):17664.","journal-title":"Sci Rep"},{"issue":"3","key":"4537_CR45","doi-asserted-by":"publisher","first-page":"e0241926","DOI":"10.1371\/journal.pone.0241926","volume":"16","author":"O Tabatabaei-Malazy","year":"2021","unstructured":"Tabatabaei-Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS ONE. 2021;16(3):e0241926.","journal-title":"PLoS ONE"},{"issue":"1","key":"4537_CR46","doi-asserted-by":"publisher","first-page":"101209","DOI":"10.1016\/j.jceh.2023.06.009","volume":"14","author":"SP Tabaeian","year":"2024","unstructured":"Tabaeian SP, Rezapour A, Azari S, Martini M, Saran M, Behzadifar M, et al. Prevalence of Non-alcoholic fatty liver disease in iran: A systematic review and Meta-analysis. J Clin Exp Hepatol. 2024;14(1):101209.","journal-title":"J Clin Exp Hepatol"},{"issue":"8","key":"4537_CR47","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/jn\/138.8.1469","volume":"138","author":"A Esmaillzadeh","year":"2008","unstructured":"Esmaillzadeh A, Azadbakht L. Food intake patterns May explain the high prevalence of cardiovascular risk factors among Iranian women. J Nutr. 2008;138(8):1469\u201375.","journal-title":"J Nutr"},{"issue":"1","key":"4537_CR48","doi-asserted-by":"publisher","first-page":"e89709","DOI":"10.5812\/ijem.89709","volume":"18","author":"N Naderinejad","year":"2020","unstructured":"Naderinejad N, Ejtahed HS, Asghari G, Mirmiran P, Azizi F. Dietary patterns and risk of chronic kidney disease among Tehranian adults with high blood pressure. Int J Endocrinol Metab. 2020;18(1):e89709.","journal-title":"Int J Endocrinol Metab"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04537-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:09:32Z","timestamp":1761656972000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4537"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04537-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed the Declaration of Helsinki guidelines and was approved by the institutional ethics committee of Fasa University of Medical Sciences (IR.FUMS.REC.1400.015). All participants gave written informed consent after being informed of the study\u2019s purpose and procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"596"}}